Category: Press Release - Page 15 - Psychedelic Alpha

Read more about the article Terran Biosciences discovers what may be the first new salts, co-crystals, and polymorphs of psilocybin in history, publishes PCT patent application, and files psilocybin Drug Master File (DMF) with FDA

Terran Biosciences discovers what may be the first new salts, co-crystals, and polymorphs of psilocybin in history, publishes PCT patent application, and files psilocybin Drug Master File (DMF) with FDA

Post published:May 19, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES FIRST EVER NAGOYA PROTOCOL-COMPLIANT SHIPMENT OF IBOGA FROM GABON

FILAMENT HEALTH ANNOUNCES FIRST EVER NAGOYA PROTOCOL-COMPLIANT SHIPMENT OF IBOGA FROM GABON

Post published:May 17, 2023
Post category:Press Release

Read more about the article Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market

Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market

Post published:May 17, 2023
Post category:Press Release

Read more about the article Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

Post published:May 17, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Post published:May 13, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder

Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder

Post published:May 12, 2023
Post category:Press Release

Read more about the article Terran Biosciences announces publication of four PCT patent applications covering breakthroughs in novel empathogens, including improved versions of methylone, ethylone, MDEA, MDAI, and MBDB

Terran Biosciences announces publication of four PCT patent applications covering breakthroughs in novel empathogens, including improved versions of methylone, ethylone, MDEA, MDAI, and MBDB

Post published:May 11, 2023
Post category:Press Release

Read more about the article GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights

GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights

Post published:May 11, 2023
Post category:Press Release

Read more about the article Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership

Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership

Post published:May 11, 2023
Post category:Press Release

Read more about the article Sunstone Therapies to present data on the long-term efficacy of psilocybin therapy in cancer patients with major depressive disorder (MDD) at the ASCO 2023 Annual Meeting

Sunstone Therapies to present data on the long-term efficacy of psilocybin therapy in cancer patients with major depressive disorder (MDD) at the ASCO 2023 Annual Meeting

Post published:May 11, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.